Abstract
Liver transplantation means surgical replacement of a diseased liver with a healthy liver. The survival rate used to be 30 % after 1 year and LTx was considered to be the last procedure when all medical or surgical intervention failed. Advances in donor organ preservation, surgical techniques, patient selection, immunosuppressive regimens and treatments for opportunistic infections all have contributed to substantially improve the survival rates. Despite substantial technological, medical and surgical advances, liver transplantation remains a complex procedure that is accompanied by significant morbidity and mortality. The post-operative outcome of each patient varies greatly depending on the patient’s pre- operative state, quality of the donated organ and the complexity of the surgery. Complications occur both immediately post transplant and in the long term. Most of the problems can be satisfactorily assessed with a panel of routine LFTs results of which are generated quickly, cheaply on the analyzer which operates 24 h. Liver Function Test identifies the presence of problem but not problem itself. Abnormal results can be meaningful only when used with clinical data, radiological findings. The study includes 75 post LTx patients in three groups adults (non ACR), Pediatrics and ACR. All recipients were on immunosuppressive therapy (tacrolimus, mycophenolate and methylprednisolone), antiviral (ganciclovir), antiprotozoal, antibacterial and antifungal (fluconazole). 5 mL of blood was drawn in plain vacutainer from the post LTx patients every day for 15 days and LFT and GGT was done. Routinely performed liver function tests correlates well with clinical complications involving liver in the transplant patients. Instead of daily testing, may be alternate day analysis of LFT should be sufficient for effective monitoring of patients. The total protein and albumin and the transaminases offer little help in monitoring LFT post LTx. The elevated levels of serum GGT and ALP may be related to chronic immune damage to the transplanted liver. Serum GGT and ALP can be used as early markers for diagnosing biliary complications and can be used to asses adequacy of endoscopic treatment in the group of patients presenting early. Thus, most of the problems can be satisfactorily assed with a panel of routine LFTs generated quickly, cheaply on analyzer which operates 24 h each day. However, it must be emphasized that LFTs may identify the presence of problems but not the problem itself and the abnormal results are meaningful only when correlated with other clinical information.
Similar content being viewed by others
References
Starzl TE, Marchioro TL, VonKaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantations of the liver in humans. Surg Gynecol Obstet. 1963;117:659–79.
Brown RS Jr., Loke JR. Gastroenterology and hepatology. In: Current medicine. vol I, the Liver ed. Philadelphia: Willis C Maddrey Publication; 1994. p 14.00–14.15.
Massicotte L, Lenis S, Thibault L, Sessine M, Seel R, Roy A. Effect of low central venous pressure on blood product transfusion requirements during liver transplantation. Liver Transplant. 2006;12:117–23.
Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in United States; a disease specific analysis of the UNOS database. Liver Transplant. 2004;10:886–97.
National Institutes of health consensus development conference statement; Liver Transplantation. 1983. Hepatology. 1984;4:107S–10S.
Seaberg EC, Belle SH, Beringer KC, Schivins JL, Detre KM. Liver transplantation in the United States from 1987-1998 updated results from Pitt-UNOS liver transplant registry. In: Cecka JM, Terasaki PI, editors. Clinical transplants 1998. vol 14. Los Angeles: UCLA Tissue Typing Laboratory; 1999. p 17–37.
Munoz SJ, Rothstein KD, Reich D, Manzarbeitia C. Long term care of liver transplant recipient. Clin Liver Dis. 2000;4:691–710.
Peter E, Potter JM, Pesce AJ. Clinical chemistry and post liver transplant monitoring. Clin Chem. 1997;43:1546–54.
Tram T, FredPoordad F, Martin P. Advances in liver transplantation. Postgrad Med. 2004;115:73–85.
Berg Meyer HU, Horder M, Rej R, International Federation of Clinical Chemistry (IFCC). Scientific committee, analytical section, approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes part-2 IFCC method for aspartate aminotransferase. J Clin Chem Clin Biochem. 1985;1986(24):497–510.
Berg Meyer HU, Horder M, Rej R, International federation of clinical chemistry (IFCC). Scientific committee, analytical section, approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes part-3 IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem. 1985;1986(24):481–95.
Tietz NW, Rinker D. Shaw LM IFCC methods for the measurement of catalytic concentration of enzymes part-5 IFCC method for alkaline phosphatase. J Clin Chem Clin Biochem. 1983;21:731–48.
Shaw M, Stromme H, London L, Theodorsen L. Part-4 IFCC method for gamma glutamyltransferase. Clin Chem Clin Biochem. 1983;21:633–46.
Tolman KG, Rej R. Liver function. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry Philadephia: WB Saunders Company; 1999. p 1136–37.
van den Hymans Bergh AA, Mueller P. Ueber eine direkte and indirekte diazoreaktion auf bilirubin. Biochem Z. 1916;77(77):90–103.
Weichsel Baum TC. An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Am J Clin Pathol. 1946;16:40–8.
Dourmas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta. 1971;31:87–96.
Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology. 1991;14:721–9.
Klintmalm GB, Nery JR, Husberg BS, Gonwa TA, Tillery GW. Rejection in liver transplantation. Hepatology. 1989;10:978–85.
Emond JC, Thistlethwaite JR, Baker AL. Rejection in liver allograft recipients: clinical characterization and management. Clin Transplant. 1987;1:143–50.
Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet. 1988;167:474–84.
Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology. 1989;9:204–9.
Krom RA, Wiesner RH, Rettke SR, Ludwig J, Southorn PA, Hermans PE, Taswell HF. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc. 1989;64:84–94.
Goldberg DM. Diagnostic enzymology. In: AG Gornall, editor. Applied biochemistry of clinical disorders. Hagerstown: Harper & Row; 1972. p 122–23.
Liu F, Li Y, Lan X, Wei Y-G, Li B, Yan L-N, Wen T-F, Zhao J-C, Xu M-Q, Wang W-T, Yang J-Y. Tacrolimus dosage requirements in living donor liver transplant recipients with small- for-size grafts. World J Gastroenterol. 2009; 15:3931–6.
Kryszewski AJ, Neale G, Whieield JB, Moss DW. Enzyme changes in experimental biliary obstruction. Clin Chim Acta. 1973;47:175–82.
Knight JA, Haymond RE. Gamma-glutamyltransferase and alkaline phosphatase activities compared in serum of normal children and children with liver disease. Clin Chem. 1981;27:48–51.
Lombardi B. On the nature, properties and significance of oval cells. In: Pani P, Feo F, Columbano A, editors. Recent trends in chemical carcinogenesis. vol 1. Cagliari, Italy: ESA; 1982. p. 37–56.
Tanaka M. A histochemical study on the activity of y-glutamyl- transpeptidase in liver disease. Acta Pathol Jpn. 1974;24:651–5.
Hickman PE, Lynch SV, Potter JM, Walker NI, Strong RW, Clouston AD. Gamma glutamyl transferase as a marker of liver transplant rejection. Transplantation. 1994;57:1278–80.
Mahajani RV, Cotler SJ, Uzer MF. Efficacy of endoscopic management of anastomotic biliary strictures after hepatic transplantation. Endoscopy. 2000;32:943–9.
Yi M, Wang G-D, He X-S, Li J-L, Zhu X-F, Hu R-D. Clinical and pathological analysis of acute rejection following orthotopic. Liver Transplant. 2009;122:1400–3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naik, P., Sritharan, V., Bandi, P. et al. A Single Centre Prospective Study of Liver Function Tests in Post Liver Transplant Patients. Ind J Clin Biochem 28, 38–45 (2013). https://doi.org/10.1007/s12291-012-0245-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0245-4